Indication

Esophageal candidiasis

Esophageal candidiasis is an opportunistic fungal infection of the esophageal mucosa, representing the most common cause of infectious esophagitis. Read more about Esophageal candidiasis

137 drugs 87 manufacturers

Advertisement

Drugs that treat it

Common Esophageal candidiasis therapies.

Showing 136–137 of 137 drugs

VORICONAZOLE

ANTIFUNGALS-SYSTEMIC·DISSEMINATED CANDIDIASIS·+6
PHARMACEU ASSOC

FLUCONAZOLE

ANTIFUNGALS-SYSTEMIC·ORAL CANDIDIASIS·+11
HAWAII REPACK,
Filter & compare in the drug finder →Opens the drug finder with Esophageal candidiasis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Esophageal candidiasis.

Esophageal candidiasis is an opportunistic fungal infection of the esophageal mucosa, representing the most common cause of infectious esophagitis.

Primarily caused by *Candida albicans*, it typically affects immunocompromised populations, including individuals with advanced HIV infection, hematologic malignancies, or diabetes, as well as patients receiving systemic corticosteroids, chemotherapy, or broad-spectrum antibiotics.

The condition occurs when impaired host defenses permit fungal proliferation and tissue invasion, leading to the formation of characteristic diffuse, creamy white mucosal plaques that can progress to ulcerations.

Hallmark clinical manifestations include odynophagia, dysphagia, and retrosternal chest pain, often occurring alongside oropharyngeal candidiasis.

Personalize your experience

Follow Esophageal candidiasis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it